C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/30/2002	EP1252312A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof
10/30/2002	EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002	EP1252306A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr
10/30/2002	EP1252305A2 Full-length human cdnas encoding potentially secreted proteins
10/30/2002	EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
10/30/2002	EP1252299A2 Aspartyl proteases
10/30/2002	EP1252298A2 Phosphodiesterases
10/30/2002	EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252296A1 Method and system for determining parameters of a protocol for deferred use of immunocompetent cells
10/30/2002	EP1252295A1 Improved inhibition of graft versus host disease
10/30/2002	EP1252293A1 Liver tissue source
10/30/2002	EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002	EP1252188A2 G-protein coupled receptors
10/30/2002	EP1252187A2 Fil-1 theta dnas and polypeptides
10/30/2002	EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252177A1 Ligand for vascular endothelial growth factor receptor
10/30/2002	EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1251872A1 Compositions and methods for treating cell proliferation disorders
10/30/2002	EP1251731A2 Protein kinase stress-related proteins and methods of use in plants
10/30/2002	EP1140973A4 Protein-protein interactions in neurodegenerative disorders
10/30/2002	EP1129176A4 Embryonic stem cells
10/30/2002	EP1096849B1 A PROCESS FOR PRODUCTION AND SUBSEQUENT $i(EX VITRO) SOWING AND PROPAGATION OF PRE-GERMINATED PLANT SOMATIC EMBRYOS
10/30/2002	EP0918509A4 Biocompatible devices with foam scaffolds
10/30/2002	EP0885298A4 Plastid transformation in arabidopsis thaliana
10/30/2002	EP0699076B1 Otitis media vaccine
10/30/2002	EP0689552B1 A method of detecting rupture of the amniotic membranes in pregant mammals
10/30/2002	EP0630403B1 Methods for the regulation of plant fertility
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377416A Sink protein
10/30/2002	CN1377414A Self-cleaving RNA sequences and their use for the control of protein synthesis
10/30/2002	CN1377411A BASB 119 polypeptide and polynucleotide from noraxella catarrhalis
10/30/2002	CN1377410A Nucleic acids and proteins from group B streptoccus
10/30/2002	CN1377225A Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine
10/30/2002	CN1376779A Process for separating cells and its application
10/30/2002	CN1093562C Reversible membrane insert for growing tissue organ
10/30/2002	CA2383819A1 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
10/30/2002	CA2344208A1 Method
10/29/2002	US6472587 Production of a 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-tolerant plant by expressing an exogenous 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-binding antibody in the plant
10/29/2002	US6472586 Nuclear-encoded transcription system in plastids of higher plants
10/29/2002	US6472515 Response element
10/29/2002	US6472376 Gene therapy
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472225 Identifying a patient donor pair based on the measured in vitro immune responses of patient lymphocytes to donor allogeneic mononuclear cells (mnc) and determining the presence of antibodies
10/29/2002	US6472212 Methods and compositions for genetically modifying primate bone marrow cells
10/29/2002	US6472211 Amplification of transcription of preferential genes; obtain cell, incubate with regulatory protein, monitor propagation of cells
10/29/2002	US6472210 Glycolic acid-lactic acid copolymer scaffold has utility for tissue engineering, particularly as a scaffold for in vitro and in vivo cell growth
10/29/2002	US6472205 Expression control sequences adapted for function in eukaryotic cell, operably linked to sequence coding cytosolic beta-lactamase; screening by contacting host cell with membrane permeable, fluorescent substrate of beta-lactamase
10/29/2002	US6472195 Human kallikrein
10/29/2002	US6472181 Hybrid matrix implants and explants
10/29/2002	US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002	US6472175 Using a baculovirus expression system, such that the recombinant nucleic acid being expressed in baculovirus expression system codes for a protein with n-linked glycosylation
10/29/2002	US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002	US6471993 Microstructure having voids located within said semi-solid network; tissue engineering scaffolds
10/29/2002	US6471959 Human transferase
10/29/2002	US6471958 Non-contracting tissue equivalent
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	EP0960196A4 Novel receptor that causes cell death
10/29/2002	CA2215922C Methods for screening compounds for estrogenic activity
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2063431C Receptors for fibroblast growth factors
10/25/2002	EP0981604A4 Targeted gene modification by parvoviral vectors
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002084281A1 Encapsulated cell indicator system
10/24/2002	WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083925A2 Papaya ringspot virus genes
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083892A2 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	WO2002083888A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083878A1 Method for autologous transplantation
10/24/2002	WO2002083877A1 Production of tyrosine hydroxylase positive neurons
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083867A2 Ires enabled gene trapping in plants
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083864A2 Methods and reagents for cell transplantation
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083849A2 Vascular endothelial growth factor 2
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083845A2 Modulation of primary stem cell differentiation
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002	WO2002083738A1 Cyclic single strand trispecific antibody

1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 1827